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ABSTRACT  residue phenylalanine 71 of the β-chain of penicillin acylase from E. coli is involved in substrate binding and chiral discrimination of its enantiomers. 
Different amino acid residues have been introduced at position βF71, and the mutants were studied with respect to their enantioselectivity and substrate specifi-
city. Some mutants demonstrated remarkably improved catalytic activity. Moreover, mutation of βF71 residue allowed to enhance penicillin acylase enantioselec-
tivity. the catalytic activity to the specific substrates was improved up to 36 times, most notably for K, r, and L mutants. Increased activity to a D-phenylglycine 
derivative – a valuable specificity improvement for biocatalytic synthesis of new penicillins and cephalosporins – was shown for βF71r and βF71L mutants. the 
synthetic capacity of penicillin acylase with 6-aminopenicillanic acid as an external nucleophile was especially sensitive to mutation of the β71 residue in contrast 
to the synthesis with 7-aminodeacetoxycephalosporanic acid.
Keywords: penicillin acylase; βF71 mutants; enantioselectivity; improved catalysis;
Abbreviations: PA – penicillin acylase; ntn – n-terminal nucleophile; Wt – wild type.
INTRODuCTION
Penicillin acylase (PA) from Escherichia coli is probably the 
most studied enzyme among the group of ntn-hydrolases. 
the enzymes of this superfamily are characterized by their 
unique catalytic mechanism in which the n-terminal amino 
acid residue (serine, cysteine or threonine) acts as a nucleo-
phile to form an acylenzyme intermediate. PАs, as well as 
other ntn-hydrolases, are activated by processing of a pre-
cursor protein to form the mature enzyme that has an αββα-
fold topology of helices and strands around the active site [1]. 
Despite the high interest in the structure and biosynthesis of 
PAs [2-13], as well as in the new synthetic applications [14-
20], little work has been done on the substrate specificity and 
especially the enantioselectivity of these enzymes [21, 22]. the 
reason for this is that the substrate specificity studies with 
phenylacetylated compounds are seriously complicated by 
a very strong competitive inhibition by the reaction product 
phenylacetic acid [23, 24]. PAs seem to possess a much wider 
substrate range than previously assumed (especially concern-
ing the leaving group), and acylases of different origins may 
have quite different catalytic activities and enantioselectivi-
ties [24]. the substrate specificity and catalytic properties of 
PAs are of very high practical interest as this family of en-
zymes plays a decisive role in the biocatalytic preparation of 
semisynthetic β-lactam antibiotics [25].
A breakthrough in the elucidation of the catalytic mecha-
nism of PA from E. coli was obtained when the X-ray crys-
tallographic structure of the native enzyme [2, 10] and an 
enzyme-substrate complex was solved [12, 13]. this provided 
the first information about the residues involved in binding 
of the leaving group of the substrate. Afterwards, molecular 
modeling has helped to reveal the intimate details of the sub-
strate binding in the penicillin acylase active center, especial-
ly concerning the binding pattern of the leaving group [26]. 
Additional contacts with residues βG385, βS386, and βn388 
have been found, which were missing in X-ray structures. 
Based on structural information and molecular modeling, the 
key amino acid residues that control interactions between the 
enzyme and substrate have been identified. Such insight is of 
crucial importance for the rational redesign of basic biocata-
lytic properties, including substrate specificity, enantioselec-
tivity, and the catalytic activity. Amino acid residue F71 of 
the β-chain of PA was demonstrated to be one of the principal 
amino acid residues interacting with the substrate’s leaving 
group. Such a residue is an attractive target for mutagenesis 
aimed at modifying the catalytic performance of PA for the reSeArcH ArtIcLeS
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biocatalytic modification of β-lactam antibiotics, chiral reso-
lution of amino compounds, etc. In this paper, we report our 
results on the modification of the major catalytic properties 
of PA from E. coli: enhancement of the enantioselectivity and 
improvement of the catalytic activity. these changes were 
obtained by mutating a single amino acid residue (βF71) in 
the enzyme’s active center.
MATERIALS AND METHODS
Mutagenesis of residue βF71 was achieved using three Pcr 
reactions. the first reaction contained the BStFW primer, 
5’-cAGGGAAGAAccGGGAAActAttG-3’, as the for-
ward primer and the F71rV reverse primer carrying the 
mutation in the codon for βF71 at the underlined position, 
5’-AAAAAtAtcGAcAtcGtcGccccAAcctGccGt-3’. 
the second reaction contained F71FW 5’-GGcGAcGAt-
GtcGAtAttttt-3’ as the forward primer and nHerV 
5’-cActcctGccAAtttttGGccttc-3’ as the reverse 
primer. Products from both reactions were isolated from 
gel and used together in a third reaction without wild-type 
template, to which also the primers nHerV and BStFW were 
added. the resulting products, carrying the mutations on po-
sition βF71, were cut with BstX1 and nheI and ligated into 
pec, which was digested with the same enzymes. Ligation 
mixtures were used to transform competent E. coli cells as 
described [27]. PA genes from the resulting transformants 
were sequenced to confirm the mutations and the absence of 
second-site mutations that might have been introduced by 
Pcr. expression and purification of mutants, as well as Wt 
PA, was done as described [12].
the concentration of active PA was determined by titra-
tion with phenylmethylsulfonylfluoride as described earlier 
[28]. Kinetic studies were performed by the initial rate analy-
sis of corresponding reactions according to [24, 30]. enantiose-
lectivity (e) of the Wt PA and its mutants was characterized 
as a ratio of the second order rate constants determined for 
the hydrolysis of the individual enantiomers e=(kcat/Km)L/
(kcat/Km)D as described earlier [21, 24].
Molecular dynamics simulations based on the available X-
ray structure 1H2G of βF71 [29] were done with the Gromacs 
package (www.gromacs.org) as described earlier [26]. Molecu-
lar docking was performed using Lead-Finder software from 
Moltech Ltd., russia (www.moltech.ru).
RESuLTS AND DISCuSSION
Amino acid residue F71 of the β-chain slightly moves upon 
binding of penicillin G in the active centre of PA and stays 
in close proximity to the β-lactam group, displaying van 
der Waals interactions [12]. Molecular modeling shows that 
residue βF71 plays an important role in the binding of other 
substrates, for example n-(3-carboxy-4-nitrophenyl)phe-
nylacetamide (Fig.1a)  and n-(2-hydroxy-4-nitrophenyl)
phenylacetamide (Fig.2a). Moreover, mutation of this ami-
no acid residue (Figs.1b and 2b) enhances the substrate’s 
interaction with the oxyanion hole and its orientation.  It 
therefore was expected that mutation of residue β71 might 
influence the catalytic activity of PA and change enanti-
oselectivity, as well as enzyme specificity to the leaving 
group.  consequently, βF71 mutants containing different 
functionalities in the side chain were prepared and studied 
with respect to their enantioselectivity and catalytic prop-
erties towards substrates of different chemical structures. 
All mutants were catalytically active, demonstrating that 
mutation of the βF71 residue did not influence the process-
ing and correct folding of the mutant enzymes. Phenylmeth-
ylsulfonylfluoride, the well known irreversible inhibitor and 
active site titration reagent for penicillin acylases [24, 28], 
was used to determine the active site concentration of the 
mutant enzymes. Active site titration of Wt PA and each 
mutant allowed to determine the absolute catalytic activity 
and accurately compare their catalytic properties. Kinetic 
studies included measuring the catalytic activity in the hy-
drolysis of phenylacetic acid derivatives with different, but 
structurally related leaving groups and α-amino substitu-
ent in the acyl group. the enantioselectivity of the mutants 
in the hydrolysis of n-phenylacetylated amino acids was 
used as a quantitative measure of chiral discrimination in 
the leaving group binding subsite. the most remarkable 
changes induced by the mutation of the single βF71 residue 
are discussed below.
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lar modeling of 
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CATALyTIC EFFICIENCy OF MuTANTS
to compare the catalytic efficiency of wild-type penicillin 
acylase and its mutants, we measured the kinetics of the 
hydrolysis of chromogenic phenylacetic acid and D-phe-
nylglycine derivatives (Fig.3). It can be seen that PA cata-
lytic activity has changed considerably by mutating residue 
βF71. As expected, mutation influences the specificity to the 
leaving group (Fig.4). Most tested mutants demonstrated im-
proved catalytic properties, but that was not the case with 
all tested substrates. the K, r, and L mutants showed a very 
large increase in catalytic activity only with some selected 
substrates, whereas the catalytic properties of the e mutants 
were improved to a lesser extent. βF71e mutant also had a 
decreased affinity to the substrates studied. Out of all tested 
compounds, the highest kcat was found for the βF71L mutant 
with an improvement of more than 36 times compared to the 
Wt PA. 
In addition to the improved catalytic activity, the K, r, and 
L mutants also had substantially increased affinity to differ-
ent substrates (data not shown), demonstrating that in gen-
eral the phenylalanine at position 71 is not an optimal amino 
acid residue, neither for the catalytic activity nor for the af-
finity of PA to its substrates. It was observed that mutation of 
βF71 changes the properties of the acyl group binding subsite 
and improves PA specificity to D-phenylglycine derivatives, 
which are key acyl donors in enzymatic synthesis of the most 
important semisynthetic penicillins and cephalosporins, such 
as ampicillin and cephalexin. the search for new PAs that 
are more specific to D-phenylglycine derivatives has a long-
lasting history [31-33], and there was no expectation that the 
specificity of PA from E. coli can be improved for this group 
of compounds. However, the βF71L mutant had increased 
specificity (kcat/Km value improved by a factor of 4.4) due to 
the increased catalytic activity and the improved affinity to 
the substrate. In fact, the nature of the “optimal” residue on 
position β71 depends on the structure of the substrate con-
verted. Our results clearly indicate that mutation of residue 
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Fig.2. Molecular model-
ing of enzyme-substrate 
complexes for wild-type 
penicillin acylase (a) and 
its βF71L mutant (b) 
with N-(2-hydroxy-4-
nitrophenyl)phenylacet-
amide. Interactions of the 
substrate with oxyanion 
hole residues (βA69 
and βN241) and residue 
βQ23 are indicated by 
dotted lines
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Fig.4. Catalytic activity of wild-type penicillin acylase and its βF71 mu-
tants expressed as the value of the catalytic constants of the enzymatic 
hydrolysis of substrates presented in Fig.3reSeArcH ArtIcLeS
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βF71 may be used to design modified PAs with improved 
catalytic performance.
NuCLEOPHILE REACTIVITy STuDIES
the most straightforward quantitative way of studying 
the effect of mutations on the binding of β-lactam nuclei in 
the course of penicillin acylase-catalyzed synthesis of new 
β-lactam antibiotics would be to measure the corresponding 
binding constants. However, because of the complex kinetics 
of PA-catalyzed acyl transfer reactions [34] there is no prop-
er method to determine the nucleophile binding constant to 
that particular subsite of the enzyme. theoretical analysis 
has shown that an adequate way of characterizing the inter-
action of the nucleophile with the enzyme is to measure the 
ratio of initial synthesis and hydrolysis rates, the (S/H)ini ra-
tio, as a function of the nucleophile concentration [35]. Kinetic 
experiments were, therefore, performed with two different 
side chain donors at a fixed concentration of the β-lactam an-
tibiotic nucleus (6-APA or 7-ADcA). the results show that 
the nucleophile reactivity of 6-APA is much more sensitive 
to the amino acid located at position β71 compared to that of 
7-ADcA (table 1). Obviously, mutation of βF71, especially 
substitution of the phenylalanine for a charged amino acid 
residue, leads to a substantial change of the β-lactam binding, 
and, as a result, the specificity of the leaving group binding 
subsite is modified.
ENANTIOSELECTIVITy
Since residue βF71 interacts with the leaving group of the 
substrate, mutating it should influence PA reactivity towards 
the stereochemical isomers of chiral substrates. therefore, 
the enzyme’s enantioselectivity value e (a ratio of kcat/Km 
values for conversion of L- and D-enantiomers of the sub-
strate) in the hydrolysis of n-phenylacetylated amino acids 
was chosen as a quantitative parameter to describe the effect 
Table 1. Initial synthesis/hydrolysis rate ratios (S/H)ini for the ampicil-
lin, amoxicillin and cephalexin synthesis catalyzed by wild-type penicillin 
acylase and its βF71 mutants using D-phenylglycine amide (D-PGA) and 
D-p-hydroxyphenylglycine amide (D-HPGA) as acyl donors
enzyme  D-PGA/7-
ADcA D-PGA/6-APA D-HPGA/6-
APA
wild type 9 ± 2 1.9 ± 0.1 1.2 ± 0.04
bF71Y 7.5 ± 0.4 0.74 ± 0.01 0.61 ± 0.03
bF71L 4.9 ± 0.4 0.94 ± 0.04 0.86 ± 0.03
bF71W 2.9 ± 0.2 0.77 ± 0.05 0.62 ± 0.03
bF71r 1.8 ± 0.03 0.76 ± 0.01 0.45 ± 0.01
bF71K 1.2 ± 0.01 0.51 ± 0.01 0.46 ± 0.02
experimental conditions: pH 7.0, 250c, 0.05 M phosphate; D-PGA and 
D-HPGA concentration 0.015 M, 6-APA and 7-ADcA – 0.025 M.
of mutations. Although the Wt PA exhibits already a very 
good chiral discrimination of n-phenylacetyl-phenylglycine 
enantiomers due to the orientation of the L-form of substrate 
in the active site by βr263 residue (Fig.5), it was still pos-
sible to improve it (Fig.6). the mutant that was superior in 
its catalytic activity, βF71L, displays a markedly decreased 
enantiopreference by almost one order of magnitude, while 
the βF71e and βF71K mutants reveal a three and six-fold 
increase, respectively. the positive effect of the mutation (i.e. 
the higher enantioselectivity) originated in the decreased af-
finity for the slow-reacting D-enantiomer, while negative 
effects are mainly caused by the altered reactivity of both 
enantiomers (data not shown). enantioselectivity, as well as 
a b
bPhe71
bPhe71
bAsn241
bAsn241
bArg263
bArg263
bAla69
bAla69
aPhe146 aPhe146
aArg145 aArg145
Fig.5. Molecular 
modeling of enzyme-
substrate com-
plexes for wild-type 
penicillin acylase with 
N-phenylacetyl-L-
phenylglycine (a) 
and N-phenylacetyl-
D-phenylglycine (b). 
Interactions of the 
L-form and the D-
form of the substrate 
with oxyanion hole 
residues (βA69 and 
βN241) are indicated 
by dotted lines. In-
teraction of the sub-
strate with residue 
βR263 is observed 
only with the L-form 
of the substrate98 | ActA nAturAe |  № 3 2009
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catalytic activity studies, shows that PA catalytic properties 
can be finely tuned by mutating the βF71 residue for the spe-
cific substrate of interest.
CONCLuSIONS
residue βF71 of PA from E. coli strongly influences the cat-
alytic activity and chiral discrimination of the substrate’s 
enantiomers. Depending on the structure of the substrate, 
βF71 mutations may deteriorate or improve the catalytic rate, 
enantioselectivity, or affinity. this indicates that a universal 
improvement of all major catalytic properties for biocatalytic 
application is hardly possible, and that the enzyme should be 
fine-tuned for its specific substrate of interest. the availabil-
ity of structure/function insight concerning specific residues 
and molecular modeling can facilitate the design of a toolbox 
of dedicated PAs for different applications.  
This work was supported by the Russian Federal Agency for 
Science and Innovation (federal contract 02.527.11.0001), 
the Seventh Framework Programme (FP7) of the European 
Commission and the Dutch Ministry of Economics.
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Fig.6. Enantioselectivity (E) of penicillin acylase mutants in the hydrolysis 
of N-phenylacetyl-phenylglycine, expressed as the ratio (kcat/Km)L / 
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reFerenceS
Oinonen c., rouvinen J. //  1.  Protein Sci., 2000, V.9, P.2329-2337.
Duggleby H.J., tolley S.P., Hill c.P., Dodson e.J., Dodson G., Moody P.c.e. //  2.  Nature, 
1995, V.373, P.264-268.
Brannigan J.A., Dodson G., Duggleby H.J., Moody P.c., Smith J.L., tomchik D. r., Mur- 3. 
zin A.G. // Nature, 1995, V.378, P.416-419.
Isupov M.n., Obmolova G., Butterworth S., Badet-Denisot M.A., Badet B., Polikarpov I.,  4. 
Littlechild J.A., teplyakov A. // Structure, 1996, V.4, P.801-810.
Groll M., Ditzel L., Lowe J., Stock D., Bochtler M., Bartunik H.D., Huber r.//  5.  Nature, 
1997, V.386, P.463-471.
Guo H.c., Xu Q., Buckley D., Guan c. //  6.  J. Biol. Chem., 1998, V.273, P.20205-20212.
McDonough M.A., Klei H.e., Kelly J.A. //  7.  Protein Sci., 1999, V.8, P.1971-1981.
Suresh c.G., Pundle A.V., rao K.n., Sivaraman H., Brannigan J.A., McVey c.e., Verma  8. 
c.S., Dauter Z., Dodson e.J., Dodson G.G., Nature Struct. Biol., 1999, V.6, P.414-416.
Schumacher G., Sizmann D., Haug H., Buckel P., Bock A. //  9.  Nucleic Acid Res., 1986, 
V.14, P.5713-5727.
Done S.H., Brannigan J.A., Moody P.c.e., Hubbard r.e. //  10.  J. Mol. Biol., 1998, V.284, 
P.463-475.
Hewitt L., Kasche V., Lummer K., Lewis r.J., Murshudov G. n., Verma c. S., Dodson  11. 
G.G., Wilson K.S. // J. Mol. Biol., 2000, V.302, P.887-898.
Alkema W.B.L., Hensgens c.M.H., Kroezinga e.H., De Vries e., Floris r., Van der Laan  12. 
J.-M., Dijkstra B.W., Janssen D.B. // Protein Eng., 2000, V.13, P.857-863.
McVey c.e., Walsh M.A., Dodson G.G., Wilson K.S., Brannigan J.A. //  13.  J. Mol. Biol., 
2001, V.313, P.139-150.
Baldaro e., D’Arrigo P., Pedrocchi-Fantoni G., rosell c.M., Servi S., tagliani A., ter- 14. 
reni M.// Tetrahedron: Asymmetry, 1993, V.4, P.1031-1034.
Waldmann, H., Sebastian D. //  15.  Chem. Rev., 1994, V.94, P.911-937.
Soloshonok V.A., Soloshonok I.V., Kukhar V.P., Љvedas V.K. //  16.  J. Org. Chem., 1998, 
V.63, P.1878-1884.
topgi r.S., ng J.S., Landis B., Wang P., Behling J.r. //  17.  Bioorg. Med. Chem., 1999, 
P.2221-2229.
Basso A., De Martin L., ebert c., Gardossi L., Linda P.// J 18.  . Mol. Cat. B: Enzymatic 
2001, V.16, P.73–80.
Guranda D.t., Van Langen L.M., Van rantwijk F., Sheldon r.A., Љvedas V.K. //  19.  Tetra-
hedron: Asymmetry, 2001, V.12, P.1645-1650.
Guranda D. t., Khimiuk A.I., Van Langen L.M., Van rantwijk F., Sheldon r. A., Svedas  20. 
V.K. // Tetrahedron: Asymmetry, 2004, V.15, P.2901-2906.
Љvedas V.K., Savchenko M.V., Beltser A.I., Guranda D.F. //  21.  Annals N.Y. Acad. Sci., 
1996, V.799, P.659-669.
Galunsky B., Lummer K., Kasche V. //  22.  Monatsh. Chem., 2000, V.131, P.623-632.
Berezin I.V., Klyosov A.A., nys P.S., Savitskaya e.M., Љvedas V.K. //  23.  Antibiotiki 
(rus.), 1974, V.19, P.880-887.
Svedas V.K., Guranda D.t., Van Langen L.M., Van rantwijk F., Sheldon r.A. //  24.  FEBS 
Lett., 1997, V.417, P.414-418.
Bruggink A., roos e.c., De Vroom e. //  25.  Org. Process Res. Dev., 1998, V.2, P.128-133.
chilov G.G., Stroganov O.V., Svedas V.K. //  26.  Biochemistry (Moscow), 2008, V.73, №1, 
P.56-64.
Sambrook J., Fritsch e. F., Maniatis t. //  27.  Molecular cloning, a laboratory manual, 2nd 
edition, cold Spring Harbor Laboratory Press, new York, 1989.
Љvedas V.K., Margolin A.L., Sherstyuk S.F., Klyosov A.A., Berezin I.V. //  28.  Bioorg. 
Khim., 1977, V.3, P.546-554.
Morillas M., McVey c.e., Brannigan J.A., Ladurner A.G., Forney L.G., Virden L. //  29. 
Biochem.J., 2003, V.371, P.143-150.
Youshko M.I., Shamolina t.A., Guranda D.F., Sinev A.V., Љvedas V.K. //  30.  Biochemistry 
(Moscow), 1998, V.63, №9, P.1104-1109.
takahashi t., Yamazaki Y., Kato K., Isona M.//  31.  J. Am. Chem. Soc., 1972, V.94, P.4035-
4037.
Blinkovsky A.M., Markaryan A.n. //  32.  Enzyme Microb. Technol., 1993, V.15, P.965-973.
Polderman-tijmes J.J., Jekel P.A., van Merode A., Floris t.A.G., van der Laan J.-M.,  33. 
Sonke t., Janssen D.B. // Appl. Environ. Microbiol, 2002, V.68, P.211-218.
Youshko M.I.,  34.  Švedas V.K. // Biochemistry (Moscow), 2000, V.65, №12, P.1367-1375. 
Youshko M.I., chilov G.G., Shcherbakova t.A., Svedas V.K. //  35.  Biochim. Biophys. Acta: 
Proteins & Proteomics, 2002, V.1599, №1-2, P.134-140.